(Press-News.org) Scientists say amending an EU directive on GMOs could help stimulate innovation in making vaccines, cheaper pharmaceuticals and organic plastics using plants.
In a paper to be published in Current Pharmaceutical Design, six scientists from the US and Europe compare risk assessment and regulation between the two continents. They will run a web chat on the subject with Sense About Science from 12-1 on Wednesday 20th February.
In the EU, plant-made pharmaceuticals have to be authorised in the same way as GM agricultural crops. In theory, agricultural crops can be grown by any farmer in the EU once approved. But for crops producing pharmaceuticals this would never actually happen. Drug companies would likely license farmers to grow these crops under controlled, defined and confined conditions.
"We need tight regulations enforced by continuous oversight to encourage investment, while maintaining trust," said Dr Penny Sparrow from the John Innes Centre.
"This will be of high importance, especially in Europe, where the issues surrounding the cultivation of GM agricultural crops remains a contentious concern."
"Plant-made pharmaceuticals challenge two sets of existing EU regulations and to make progress in this area we need to make sure they are applied sensibly to allow pharmaceuticals to be produced in plants."
Advantages of using plants to produce therapeutic proteins include the ability to produce large quantities quickly and cheaply, the absence of human pathogens, the stability of the proteins and the ease with which raw material can be stored as seed. This could be of huge benefit in developing countries where problems with storage can render vaccines useless.
If seed could be transported to local production and extraction facilities, the technology could also help boost local economies. The technology is also known as "plant molecular farming".
Just one farm growing 16,000 acres of safflower could meet the world's total demand for insulin. But potential cost savings are eliminated under current regulations, set up for GM agricultural crops not pharmaceuticals.
The average cost for having GMOs approved in Europe is estimated at €7-10 million per event, compared to $1-2 million in the US. This helps keep Europe behind in exploiting the potential of these technologies.
"Openness and transparency are needed to develop new regulations that work for the public and for investors," said Sparrow.
"Regulations need to be harmonised across the world, in order to keep advances and competition on a level playing field."
They propose amendments to EU Directive 2001/18 to allow pharmaceutical products from GM plants to be commercialised without needing authorisation to enter the human food or animal feed chain. Instead, the scientists say they should be grown under clearly defined and enforced conditions to keep the food and animal feed chain 'contamination free'.
As each GM plant moves from the laboratory to scaled-up production in a greenhouse or field, additional oversight is needed to consider issues with environmental release and the ultimate use by humans. Measures can include those adopted in the US, such as limited acreage, confinement, fallow zones and only supplying seed to farmers specifically contracted to grow PMPs.
Dr Sparrow was involved in a collaboration with EU partners to road test the challenges faced by potential investors. They chose the first plant-derived anti-HIV monoclonal antibody to be tested in humans. It was isolated, purified and formulated as a topical saline solution. One result of the project was preparing a regulatory pathway that others could follow to take a product into clinical trials. Another was establishing good manufacturing practices for biologically active proteins expressed in transgenic plants.
###
Contact
To arrange pictures or interviews please contact Zoe Dunford at the JIC press office: +44 (0)1603 255111, 07768 164185, zoe.dunford@jic.ac.uk
To participate in the web chat
Questions for the live #plantsci Q&A with the authors can be sent via email to plantsci@senseaboutscience.org, via Twitter using #plantsci or via the Sense About Science Facebook page.
Reference
Risk assessment and regulation of molecular farming – a comparison between Europe and US.
Notes to editors
About the John Innes Centre
The John Innes Centre, www.jic.ac.uk, is a world-leading research centre based on the Norwich Research Park www.nrp.org.uk. The JIC's mission is to generate knowledge of plants and microbes through innovative research, to train scientists for the future, and to apply its knowledge to benefit agriculture, human health and well-being, and the environment. JIC delivers world class bioscience outcomes leading to wealth and job creation, and generating high returns for the UK economy. JIC is one of eight institutes that receive strategic funding from the Biotechnology and Biological Sciences Research Council.
Live Q&A: Wed 20th Feb, 12-1pm
Plants can be modified to 'grow' medicines. For example, insulin can be 'grown' in a GM safflower plant, which would be cheaper and more efficient than current methods. These plant-made pharmaceuticals are never likely to enter the food-chain but they fall under the same EU regulations as GM crops that are grown as food. The EU GM regulatory system is lengthy and costly, making the cheaper plant-made alternative production method prohibitively expensive.
In a soon to be published paper, a comparison between the US and EU regulations surrounding plant-made pharmaceuticals is made and the authors discuss whether EU regulation hinders progress and investment into these new technologies. Sense About Science will be running a live #plantsci Q&A with the authors on Wednesday 20th February from 12-1pm UK time. You can start sending questions, concerns and ideas now, on any aspect of this, for the authors to respond to.
Questions can be sent via email to plantsci@senseaboutscience.org, via Twitter using #plantsci or via the Sense About Science Facebook page.
http://www.senseaboutscience.org/pages/using-gm-plants-to-grow-medicine.html
#GM plants to 'grow' medicine - Live #plantsci Q&A from @senseaboutsci, Wed 20th Feb, 12-1pm http://ow.ly/hIoMM
'Growing' medicines in plants requires new regulations
2013-02-19
ELSE PRESS RELEASES FROM THIS DATE:
Quick, efficient chip cleans up common flaws in amateur photographs
2013-02-19
CAMBRIDGE, Mass. — Your smartphone snapshots could be instantly converted into professional-looking photographs with just the touch of a button, thanks to a processor chip developed at MIT.
The chip, built by a team at MIT's Microsystems Technology Laboratory, can perform tasks such as creating more realistic or enhanced lighting in a shot without destroying the scene's ambience, in just a fraction of a second. The technology could be integrated with any smartphone, tablet computer or digital camera.
Existing computational photography systems tend to be software applications ...
Abnormal growth regulation may occur in children with heart defects
2013-02-19
The poor growth seen in children born with complex heart defects may result from factors beyond deficient nutrition. A new study by pediatric researchers suggests that abnormalities in overall growth regulation play a role.
"When compared with their healthy peers, children with congenital heart disease have impaired growth, as measured in weight, length, and head circumference," said senior author Meryl S. Cohen, M.D., a pediatric cardiologist in the Cardiac Center at The Children's Hospital of Philadelphia. "We investigated patterns of poor growth in these children, ...
Is there a link between childhood obesity and ADHD, learning disabilities?
2013-02-19
URBANA – A University of Illinois study has established a possible link between high-fat diets and such childhood brain-based conditions as attention deficit hyperactivity disorder (ADHD) and memory-dependent learning disabilities.
"We found that a high-fat diet rapidly affected dopamine metabolism in the brains of juvenile mice, triggering anxious behaviors and learning deficiencies. Interestingly, when methylphenidate (Ritalin) was administered, the learning and memory problems went away," said Gregory Freund, a professor in the U of I College of Medicine and a member ...
Steroid injection may lead to worse outcomes in patients with spinal stenosis
2013-02-19
Philadelphia, Pa. (February 19, 2013) - For patients with spinal stenosis, epidural steroid injections (ESI) may actually lead to worse outcomes—whether or not the patient later undergoes surgery, according to a study in the February 15 issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
The study raises questions about the benefits of steroid injection—a widely used treatment for the common problem of spinal stenosis in the lower (lumbar) spine. "There was no improvement in outcome with ESI whether patients were ...
Thigh fat may be to blame for older adults who slow down
2013-02-19
WINSTON-SALEM, N.C. – Feb. 19, 2013 – A new study from Wake Forest Baptist Medical Center shows that an increase in fat throughout the thigh is predictive of mobility loss in otherwise healthy older adults.
Lead author Kristen Beavers, Ph.D., and colleagues at Wake Forest Baptist said the findings suggest that prevention of age-related declines in walking speed isn't just about preserving muscle mass, it's also about preventing fat gain.
Walking speed declines with age, said Beavers, and in older adults slower walking speed is a predictor of disability, nursing home ...
Degenerative cervical spine disease may not progress over time
2013-02-19
Philadelphia, Pa. (February 19, 2013) - Follow-up data on patients with degenerative disease of the upper (cervical) spinal vertebrae show little or no evidence of worsening degeneration over time, according to a study in the February 15 issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
For many patients with "unstable" cervical degenerative spondylolisthesis, observation may be a better choice than surgery, according to the new research by Dr Moon Soo Park and colleagues of Medical College of Hallym University, ...
Breakthrough study opens door to broader biomedical applications for Raman spectroscopy
2013-02-19
Amsterdam, NL, 19 February 2013 – Raman spectroscopy has enabled incredible advances in numerous scientific fields and is a powerful tool for tissue classification and disease recognition, although there have been considerable challenges to using the method in a clinical setting. Scientists have now demonstrated the advantages of wavelength-modulated Raman spectroscopy, opening the door to wider biomedical and clinical applications such as real-time assessment of tissues during surgery. This study is published in Biomedical Spectroscopy and Imaging.
The inelastic scattering ...
Males' superior spatial ability likely is not an evolutionary adaptation
2013-02-19
Males and females differ in a lot of traits (besides the obvious ones) and some evolutionary psychologists have proposed hypotheses to explain why. Some argue, for example, that males' slight, but significant, superiority in spatial navigation over females – a phenomenon demonstrated repeatedly in many species, including humans – is probably "adaptive," meaning that over the course of evolutionary history the trait gave males an advantage that led them to have more offspring than their peers.
A new analysis published in The Quarterly Review of Biology found no support ...
Sports, shared activities are 'game changers' for dad/daughter relationships, Baylor study finds
2013-02-19
The most frequent turning point in father-daughter relationships is shared activity — especially sports — ahead of such pivotal events as when a daughter marries or leaves home, according to a study by Baylor University researchers.
"This is the masculine style of building closeness — called 'closeness in the doing' – whereas the feminine orientation is talking, 'closeness in the dialogue,'" said Mark T. Morman, Ph.D., a professor of communication in Baylor's College of Arts & Sciences. An article about the findings by Morman and former Baylor graduate student Elizabeth ...
Engineering cells for more efficient biofuel production
2013-02-19
CAMBRIDGE, Mass. — In the search for renewable alternatives to gasoline, heavy alcohols such as isobutanol are promising candidates. Not only do they contain more energy than ethanol, but they are also more compatible with existing gasoline-based infrastructure. For isobutanol to become practical, however, scientists need a way to reliably produce huge quantities of it from renewable sources.
MIT chemical engineers and biologists have now devised a way to dramatically boost isobutanol production in yeast, which naturally make it in small amounts. They engineered yeast ...